Find-A-Study

A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF)

Purpose

Category

Lungs, Breathing and Bronchial

IRB Number: 20220432HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Principal Investigator
Anoop Nambiar

Darcy Bair-Kelps
(210) 540-7100
bairkelps@uthscsa.edu

Hilda Pomroy
+1 (210) 450-9022
pomroy@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups